Skip to main content
. 2023 Jan 12;39:100579. doi: 10.1016/j.ctro.2023.100579

Table 3.

Univariate and multivariate logistic regression of variables predicting complete response to nCRT (neoadjuvant chemoradiation).

VARIABLE pCR, n (%) UNIVARIATE MULTIVARIATE
GENDER
Male
Female

113 (26.0)
65 (23.5)
p = 0.45
1.15 (0.81–1.63)
1.00
AGE, years
<65
≥65

81 (22.6)
97 (27.4)
p = 0.14
1.00
1.29 (0.92–1.81)
cT
1–2
3
4

14 (31.1)
122 (24.9)
33 (21.4)
p = 0.39
1.00
0.74 (0.38–1.43)
0.60 (0.29–1.26)
cN
negative
positive

30 (23.3)
143 (24.9)
p = 0.69
1.00
1.10 (0.70–1.72)
EXTRAMESORECTAL NODES
no
yes

120 (24.7)
39 (25.2)
p = 0.91
1.00
1.03 (0.68–1.56)
CONCOMITANT CT
single agent
double agent

131 (25.5)
45 (23.4)
p = 0.58
1.00
0.89 (0.61–1.32)
RT, Gy
<55
≥55

57 (21.7)
121 (26.9)
p = 0.12
1.00
1.33 (0.93–1.91)
SURGICAL INTERVAL, weeks
<12
≥12

99 (23.2)
79 (27.7)
p = 0.17
1.00
1.27 (0.90–1.79)
NLR
<=1.2
>1.2

14 (48.3)
164 (24.0)
p = 0.005
1.00
0.34 (0.160.72)
p = 0.05
1.00
0.46 (0.211.00)
PLR
<=200
>200

149 (27.6)
29 (16.9)
p = 0.005
1.00
0.53 (0.340.83)
---
SII
<=500
>500

83 (32.0)
95 (21.0)
p = 0.001
1.00
0.56 (0.400.79)
p = 0.009
1.00
0.62 (0.430.89)
MLR
<=0.38
>0.38

158 (26.9)
20 (16.0)
p = 0.012
1.00
0.52 (0.310.86)
---
HEI
0–1-2
3

158 (25.6)
20 (21.3)
p = 0.37
1.00
0.79 (0.46–1.33)

CT: chemotherapy; Gy: Gray; HEI: hemo-eosinophils inflammation index; MLR: monocyte-to-lymphocyte ratio; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; RT: radiotherapy; SII: systemic index of inflammation. In bold the statistically significant values.